Concealed Penis in Pediatric Age Group
Concealed Penis in Pediatric Age Group; A Comparison Between Three Surgical Techniques
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Alexandria, Egypt, 12345
- Faulty of Medicine
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients with a buried penis at or below the pubic skin level with a stretched penile length for all of them within the normal range according to their ages as titrated in the literature
Exclusion Criteria:
- Patients with any associated anomalies like hypospadias, torsion, penoscrotal web, micropenis, mega-prepuce, or chordae were excluded from the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Phallopexy group
phallopexy only
|
comparison of three surgical techniques (as described in the arms) in the management of concealed penis in pediatrics
|
|
Experimental: Dartos excision group
complete circumferential dissection and excision of dartos fascia only
|
comparison of three surgical techniques (as described in the arms) in the management of concealed penis in pediatrics
|
|
Experimental: Combined phallopexy and dartos excision group
phallopexy as in patients of group A but after complete dissection and excision of dartos fascia
|
comparison of three surgical techniques (as described in the arms) in the management of concealed penis in pediatrics
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post-operative appearance of penile skin congestion and/or necrosis
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards persistent bluish penile discoloration and or loss of penile skin viability.
Also a questionnaire of parents about penile skin color, loss of skin, and/or appearance of any abnormal tissues
|
6 months
|
|
Wound infection
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards the appearance of any penile skin infection and/or pyogenic discharge.
Also a questionnaire of parents about the appearance of penile skin redness, pyogenic discharge, and/or the appearance of any pyogenic membranes
|
6 months
|
|
Penile edema
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards the appearance of penile skin edema.
Also a questionnaire of parents about any increase of penile girth than the usual
|
6 months
|
|
Penile re-retraction
Time Frame: 6 months
|
Repeated and regular monthly examination of the patients as regards the development of any penile re-retraction in the form of retraction of the penis to or beneath the level of pubic skin.
Also, a questionnaire of parents about this finding was done
|
6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Ahmed EZ Elrouby, A.Professor, University of Alexandria
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 0305434
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.